Related Experiment Video
Updated: Feb 21, 2026
11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
18.0K
[New experimental strategies in cartilage surgery]
L Rackwitz1, J C Reichert1, O Pullig2
1Klinik für Orthopädie und Unfallchirurgie, Evangelisches Waldkrankenhaus Spandau, Stadtrandstraße 555, 13589, Berlin, Deutschland.
Der Orthopade
|October 11, 2017
Summary
Novel cell and growth factor therapies show promise for cartilage repair and osteoarthritis treatment. However, more clinical trials are needed to confirm the efficacy of these regenerative medicine strategies.
Area of Science:
- Regenerative Medicine
- Orthopedics
- Biotechnology
Background:
- Cell and growth factor therapies offer significant potential for enhancing cartilage repair.
- These strategies are crucial for treating osteoarthritic joints and focal cartilage defects.
Purpose of the Study:
- To review novel experimental strategies for treating focal cartilage defects and osteoarthritis.
- Emphasis is placed on cell and growth factor-based therapeutic approaches.
Main Methods:
- Summarizing the authors' data on intraarticular stem cell injections for knee osteoarthritis.
- Providing a synopsis of significant literature on cartilage repair and osteoarthritis therapies.
Main Results:
- Current strategies involve growth factors, platelet-rich plasma (PRP), bone marrow (BMSAC), adipose-derived stromal vascular fraction (SVF), and expanded mesenchymal stem cells (MSCs).
- Early clinical data suggest potential for expanded MSCs in therapeutic applications.
- Regulatory approval and adherence to EU law are necessary for these advanced therapies.
Conclusions:
- A limited number of randomized, controlled trials are currently available for these novel strategies.
- The long-term efficacy of these cell and growth factor-based treatments cannot yet be definitively determined.
